Company: ISRG
Filing Date: 2025-05-05
Form Type: 8-K
Source: 0001035267-25-000156
Chunk: 2

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-05-05
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01.      Regulation FD Disclosure.  

On May 1, 2025, the Board of Directors of the Company increased the authorized amount available under the Company’s common stock repurchase program (the “ Repurchase Program”) to an aggregate of $4.0 billion, including amounts remaining under previous authorization.

The timing and total amount of repurchases will depend upon market conditions and may be made from time to time in open market purchases, privately negotiated transactions, accelerated share repurchase programs, issuer self-tender offers or otherwise, as determined by the Company’s management. The repurchases will be made in compliance with, and at such times as permitted by, federal securities law and may be suspended or discontinued at any time. The Repurchase Program does not obligate the Company to acquire any particular amount of common stock. The Company expects to fund the Repurchase Program through cash, cash equivalents, and investments.

  Forward-Looking Statements  

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to expectations concerning matters that are not historical facts. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “could,” “should,” “would,” “targeted,” and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to the following: statements regarding the potential repurchase by the Company of up to $4.0 billion of its common stock and the timing and form of stock repurchase transactions; and the source of funds used for such repurchases. These forward-looking statements are necessarily estimates reflecting the judgment of the Company’s management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should be considered in light of various important factors, including, but not limited to, the following: the overall macroeconomic environment, which may impact customer spending and the Company’s costs, including tariffs, the levels of inflation, and interest rates; the conflict between Ukraine and Russia; conflicts in the Middle East; disruption to the Company’s supply chain, including difficulties in obtaining a sufficient supply of materials; curtailed or delayed capital spending by hospitals; and the impact of global and regional